Olema Oncology logo

Olema Oncology

Healthcare

About

Olema Oncology is a cancer medicines company focused on developing innovative treatments for breast cancer and other malignancies. Led by palazestrant (OP-1250), a complete estrogen receptor antagonist, and OP-3136, a KAT6 pathway inhibitor, the company aims to create more effective therapies that improve patient outcomes. Olema's team is dedicated to its mission of developing better medicines with clarity and intention.

Share feedback - DM or email [email protected]
© 2026 Hirebase. All rights reserved.